Enedra Therapeutics
At Enedra, we go beyond treating visible mutations to address the root cause of tumor evolution — chromosomal instability.
Seed ·
Amount not disclosed in a source on record.
Funding history ↓Signals
Website registeredJun 4, 2021 (5 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Seed | undisclosed | — | fundraisingfox.com |
Timeline
- Website created
Founders and team
- ABAndreas Ballis CSO & Foundersource: enedratx.com
Companies like Enedra Therapeutics
AApothékary$16M Series A · Jun 2026SSplice Bio$140M Series B+ · Jun 2025
RRondo Therapeutics$67M Series A · Mar 2022
CCardiac Dimensions$53M Series B+ · Mar 2025
VVilyaSeries A · Jun 2024BBioinsights$2.75M Seed · Sep 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/enedra-therapeutics (get a free API key).